Review
Published on 26 Feb 2025
Advances in sulodexide-based long-term anticoagulation for a myasthenia gravis patient with giant thymoma
in Drugs Outcomes Research and Policies
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1543612
Type at least 3 characters
2,014 articles
Articles
Original Research
Accepted on 25 Feb 2025
Pharmacist-Led Surgical Medicines Prescription Optimization and Prediction Service Improves Patient Outcomes -A Machine Learning Based Study
in Drugs Outcomes Research and Policies
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1534552
Original Research
Published on 25 Feb 2025
Community pharmacy professionals’ knowledge, attitudes, and practices toward substandard and falsified medicines and associated factors in Bahir Dar City, Northwest Ethiopia
in Drugs Outcomes Research and Policies
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1523709
- 123 views
Original Research
Published on 25 Feb 2025
Time-varying cost-effectiveness analysis of sodium-glucose cotransporter-2 inhibitors in Chinese patients with heart failure and reduced ejection fraction: A microsimulation of the real-world population
in Drugs Outcomes Research and Policies
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1527972
Original Research
Accepted on 24 Feb 2025
Association of Rivaroxaban Plasma Trough Concentrations with Clinical Characteristics and Outcomes
in Drugs Outcomes Research and Policies
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1563745
Original Research
Accepted on 24 Feb 2025
Development and Validation of the Chinese Insulin Medication Literacy Scale (Ch-InMLS) for Patients with Diabetes Mellitus
in Drugs Outcomes Research and Policies
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1477050
Original Research
Accepted on 24 Feb 2025
Unaware and Unpowered: Evaluating Patient Perceptions and Preferences of Biosimilars in South Korea
in Drugs Outcomes Research and Policies
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1551451
Perspective
Published on 24 Feb 2025
What role for real-world evidence in market access of biosimilars?
in Drugs Outcomes Research and Policies
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1538866
- 242 views
Original Research
Published on 21 Feb 2025
Impacts of Chinese national centralized volume-based procurement policy targeting meropenem on prescription of designated antimicrobials for inpatients: an interrupted time series analysis
in Drugs Outcomes Research and Policies
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1458792
- 119 views
Original Research
Accepted on 20 Feb 2025
Differences in Risk Factors for Mortality between T2N1M0 and T3N0M0 Lobular Breast Cancer Patients: A Comparative Study
in Drugs Outcomes Research and Policies
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1550081
Original Research
Published on 19 Feb 2025
Association between hyperuricemia and all-cause mortality in people taken Statins: a retrospective cohort study
in Drugs Outcomes Research and Policies
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1533709
- 182 views
Original Research
Accepted on 17 Feb 2025
Targeting Glycolysis in Esophageal Squamous Cell Carcinoma: Single-Cell and Multi-Omics Insights for Risk Stratification and Personalized Therapy
in Drugs Outcomes Research and Policies
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1559546
Original Research
Published on 17 Feb 2025
Impact of the national health insurance coverage policy on mecapegfilgrastim utilization for chemoradiotherapy-induced neutropenia in cancer patients in China: a retrospective real-world analysis
in Drugs Outcomes Research and Policies
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1546261
- 166 views
Review
Accepted on 14 Feb 2025
Effects of perioperative anesthetics on the postoperative prognosis of patients undergoing surgery for cervical cancer
in Drugs Outcomes Research and Policies
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1536663
Original Research
Accepted on 13 Feb 2025
Undergraduate Pharmacy Students' Preference for Case-Based Learning: A Discrete Choice Experiment in China
in Drugs Outcomes Research and Policies
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1529492
Original Research
Published on 13 Feb 2025
Time in the therapeutic range, bleeding event, and their determinants in older patients with atrial fibrillation on warfarin in Ethiopia: multicenter cross-sectional study
in Drugs Outcomes Research and Policies
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1541592
- 194 views